PHP
CDNA icon

Parkman Healthcare Partners’s CareDx CDNA Stock Holding History

Parkman Healthcare Partners’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.77M Sell
202,417
-88,961
-31% -$1.94M 0.59% 55
2026
Q1 		$5.06M Buy
291,378
+15,224
+6% +$288K 0.52% 54
2025
Q4 		$5.2M Buy
+276,154
New +$4.63M 0.5% 61

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkman Healthcare Partners's CDNA Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its CareDx (CDNA) stake by 31% in Q2 2026, selling an estimated $1.94M and leaving 202,417 shares worth $5.77M. The position accounts for 0.59% of the portfolio, ranked #55.

Parkman Healthcare Partners first reported a position in CDNA in Q4 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Parkman Healthcare Partners held 202,417 shares of CareDx worth $5.77M as of Q2 2026.
  • Parkman Healthcare Partners sold 88,961 CareDx shares in Q2 2026, an estimated $1.94M.
  • CareDx made up 0.59% of Parkman Healthcare Partners's portfolio in Q2 2026, its #55 holding.
  • Parkman Healthcare Partners first reported a position in CareDx in Q4 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.